The efficacy and safety of rapamycin (Sirolimus/Rapamune) for treatment of angiomyoliomas in tuberous sclerosis complex and sporadic lymphangioleiomyomatoisis - CONVERIS Research Information System by Thomson Reuters:

Go to Header Go to Navigation Go to Content Go to Footer

Title: The efficacy and safety of rapamycin (Sirolimus/Rapamune) for treatment of angiomyoliomas in tuberous sclerosis complex and sporadic lymphangioleiomyomatoisis

Funder
Tuberous Sclerosis Association

Principal Investigator

Sampson, Julian

Project Details

Net value award figure for Cardiff University: £101,361.00

Start date: 01/07/2005

End date: 30/11/2010

Our policy towards the use of cookies